Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,722Revenue (TTM) $M233Net Margin (%)-193.4Altman Z-Score0.7
Enterprise Value $M2,865EPS (TTM) $-6.7Operating Margin %-146.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.7Pre-tax Margin (%)-151.5Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales11.25-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-727.5ROA % (ttm)-22.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-52.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.1ROIC % (ttm)-31.8Gross Margin Increase y-yN

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOVanguard Health Care Fund 2015-03-31 Add0.01%$24.32 - $31.29
($28.09)
$ 37.9635%Add 1.88%5,564,220
MDCOVanguard Health Care Fund 2014-12-31 Add0.04%$20.36 - $27.96
($24.81)
$ 37.9653%Add 14.67%5,461,430
MDCOJoel Greenblatt 2014-12-31 Sold Out -0.01%$20.36 - $27.96
($24.83)
$ 37.9653%Sold Out0
MDCOJoel Greenblatt 2014-09-30 Reduce-0.06%$22.95 - $29.64
($25.38)
$ 37.9650%Reduce -87.68%24,009
MDCOGeorge Soros 2014-09-30 Sold Out -0.02%$22.95 - $29.64
($25.38)
$ 37.9650%Sold Out0
MDCOVanguard Health Care Fund 2014-09-30 Add$22.32 - $29.64
($25.4)
$ 37.9649%Add 1.33%4,762,730
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 37.9642%New holding194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 37.9642%New holding75,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 37.9614%Sold Out0
MDCOVanguard Health Care Fund 2014-03-31 Add0.01%$27.9 - $40.39
($33.09)
$ 37.9615%Add 2.20%4,700,058
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 37.9614%Sold Out0
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 37.966%Reduce -80.00%50,000
MDCOVanguard Health Care Fund 2013-12-31 Add0.04%$31.48 - $38.91
($35.78)
$ 37.966%Add 8.20%4,599,069
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 37.966%New holding13,990
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 37.9619%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 37.9619%Add 66.67%250,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 37.9613%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 37.9613%Add 57.89%150,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 37.9624%New holding472,900
MDCOGeorge Soros 2013-03-31 Buy 0.04%$23.97 - $33.41
($30.53)
$ 37.9624%New holding95,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Shigeta HiroakiDirector 2016-07-11Sell3,849$38.5-1.4view
Shigeta HiroakiDirector 2016-06-13Sell20,000$36.763.26view
Shigeta HiroakiDirector 2016-06-13Sell20,000$36.763.26view
Cox Christopher TEVP & Chief Corp. Dev. Officer 2016-06-10Buy45,985$37.90.16view
Cox Christopher TEVP & Chief Corp. Dev. Officer 2016-06-07Buy53,340$37.551.09view
Savage Robert G.Director 2016-05-24Sell10,000$36.952.73view
Spigelman Melvin KDirector 2016-05-24Sell15,000$372.59view
MEANWELL CLIVECEO 2016-05-16Sell10,000$358.46view
CROUSE WILLIAMDirector 2016-05-16Sell15,000$35.157.99view
WYATT ELIZABETH H SDirector 2016-05-13Sell15,000$34.0711.42view

Quarterly/Annual Reports about MDCO:

News about MDCO:

Articles On GuruFocus.com
Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, Medicines Co Cangrelor Well-Recomm Apr 16 2015 
Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
George Soros' Top Buys in the Last Quarter Dec 23 2011 
George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
Medicines Company Reports Operating Results (10-Q) May 10 2010 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 

More From Other Websites
Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise? Jul 27 2016
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results Jul 27 2016
Medicines Co. posts 2Q profit Jul 27 2016
Medicines Co. posts 2Q profit Jul 27 2016
7:14 am The Medicines Co beats by $0.35, beats on revs Jul 27 2016
Q2 2016 Medicines Co Earnings Release - Before Market Open Jul 27 2016
MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 27 2016
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results Jul 27 2016
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More Jul 26 2016
Call buyers targeting Medicines Company Jul 20 2016
The Medicines Company to Announce Second Quarter Financial Results on July 27, 2016 Jul 18 2016
The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : July 12, 2016 Jul 12 2016
Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation Jul 12 2016
Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation Jul 12 2016
Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016? Jul 08 2016
http://news.investornetwork.com/2016/07/07/coverage-initiated-on-select-healthcare-equities/ Jul 07 2016
The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma Jun 30 2016
Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold Jun 29 2016
The Medicines Co.'s Carbavance Scores in Phase III Study Jun 28 2016
MEDICINES CO /DE Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial... Jun 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)